Dapiprazole

Jump to navigation Jump to search
Dapiprazole
Dapiprazole.png
Clinical data
AHFS/Drugs.comConsumer Drug Information
MedlinePlusa601043
Pregnancy
category
  • B
Routes of
administration
Topical (eye drops)
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
BioavailabilityNegligible when administered topically
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC19H27N5
Molar mass325.451 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Dapiprazole

Articles

Most recent articles on Dapiprazole

Most cited articles on Dapiprazole

Review articles on Dapiprazole

Articles on Dapiprazole in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dapiprazole

Images of Dapiprazole

Photos of Dapiprazole

Podcasts & MP3s on Dapiprazole

Videos on Dapiprazole

Evidence Based Medicine

Cochrane Collaboration on Dapiprazole

Bandolier on Dapiprazole

TRIP on Dapiprazole

Clinical Trials

Ongoing Trials on Dapiprazole at Clinical Trials.gov

Trial results on Dapiprazole

Clinical Trials on Dapiprazole at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dapiprazole

NICE Guidance on Dapiprazole

NHS PRODIGY Guidance

FDA on Dapiprazole

CDC on Dapiprazole

Books

Books on Dapiprazole

News

Dapiprazole in the news

Be alerted to news on Dapiprazole

News trends on Dapiprazole

Commentary

Blogs on Dapiprazole

Definitions

Definitions of Dapiprazole

Patient Resources / Community

Patient resources on Dapiprazole

Discussion groups on Dapiprazole

Patient Handouts on Dapiprazole

Directions to Hospitals Treating Dapiprazole

Risk calculators and risk factors for Dapiprazole

Healthcare Provider Resources

Symptoms of Dapiprazole

Causes & Risk Factors for Dapiprazole

Diagnostic studies for Dapiprazole

Treatment of Dapiprazole

Continuing Medical Education (CME)

CME Programs on Dapiprazole

International

Dapiprazole en Espanol

Dapiprazole en Francais

Business

Dapiprazole in the Marketplace

Patents on Dapiprazole

Experimental / Informatics

List of terms related to Dapiprazole

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Dapiprazole (Rev-Eyes) is an alpha blocker. It is used to reverse mydriasis after eye examination.[1]

References

  1. Doughty, Michael J.; Lyle, William M. (May 1992). "A Review of the Clinical Pharmacokinetics of Pilocarpine, Moxisylyte (Thymoxamine), and Dapiprazole in the Reversal of Diagnostic Pupillary Dilation". Optometry & Vision Science. 69 (5).

Template:Antiglaucoma preparations and miotics